Aehr Test Systems (NASDAQ: AEHR) has seen significant executive activity following a period of substantial stock price growth. Alberto Salamone, the company's Executive Vice President of PPBI Business, recently disposed of common stock in transactions valued at $2,761,950. These sales were executed across two consecutive days in April 2026.
Transaction Details
The specific breakdown of the sales shows a consistent volume over a short period. On April 20, 2026, Mr. Salamone sold 15,000 shares at $89.57 per share. The following day, April 21, 2026, he sold another 15,000 shares, this time at a price of $94.56 per share. After these transactions were finalized, his direct holdings in the company stood at 48,025 shares, a figure that incorporates shares tied to unvested restricted stock units.
Market Context and Financial Performance
This executive selling occurs while AEHR is trading near its 52-week high of $99.67. The company has seen an extraordinary return of 1,029% over the last year. However, valuation remains a point of discussion; analysis suggests that based on Fair Value assessments, the stock may currently be overvalued.
The company's recent financial history includes a $60 million at-the-market stock offering, which was part of a larger registration statement allowing for up to $100 million in securities. Furthermore, Aehr Test Systems recently secured its largest order to date: a $41 million production order from a hyperscale customer. This record order is intended for AI processor ASICs and includes high-power test systems, with deliveries expected to begin in fiscal 2027.
Analyst Outlook
Market analysts have provided varying perspectives on the company's trajectory. Freedom Broker has updated its price target for AEHR to $61 while maintaining a Hold rating. Their assessment noted that while third-quarter fiscal 2026 revenue of $10.3 million fell slightly below expected levels, the company demonstrated strong demand metrics and achieved record quarterly bookings of $37.2 million. Similarly, Lake Street raised its price target to $56 and maintained a Buy rating, citing the company's robust momentum in bookings despite the recent revenue miss.
Key Points
- Significant Executive Liquidity: The sale of over $2.7 million in stock by an EVP highlights how leadership is managing equity during periods of extreme price appreciation. This impacts the semiconductor testing sector and investor perception of internal valuation.
- Record Demand for AI Infrastructure: The $41 million order from a hyperscale customer for AI processor ASICs demonstrates high-level demand within the artificial intelligence hardware supply chain, specifically regarding high-power test systems.
- Strong Booking Momentum: Despite revenue fluctuations, the record quarterly bookings of $37.2 million suggest a strong forward-looking pipeline in the specialty testing market.
Risks and Uncertainties
- Valuation Discrepancies: With the stock trading near its 52-week high after a 1,029% rise, there is an explicit risk regarding overvaluation relative to Fair Value, which could impact capital markets stability for the ticker.
- Revenue Volatility: The recent third-quarter fiscal 2026 revenue of $10.3 million missed expectations, indicating potential uncertainty in short-term earnings execution despite high booking numbers. This affects the semiconductor equipment sector's predictability.